Investor mix
12 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 50% |
| Private equity | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 4 | 33% |
International Biopharma specializing in GPCR structure-based drug design, peptide and nanotechnology
12 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 50% |
| Private equity | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 4 | 33% |